Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Non-opioid analgesics including both selective and non-selective cyclooxygenase (COX) inhibitors and acetaminophen are the most widely used treatments for pain. Inhibition of COX is thought to be largely responsible for both the therapeutic and adverse effects of this class of drugs. Accumulating evidence over the past two decades has demonstrated effects of non-opioids beyond the inhibition of COX and prostaglandin synthesis that might also explain their therapeutic and adverse effects. These include their interaction with endocannabinoids, nitric oxide, monoaminergic, and cholinergic systems. Moreover, the recent development of microarray technology that allows the study of human gene expression suggests multiple pathways that may be related to the analgesic and anti-inflammatory effects of non-opioids. The present review will discuss the multiple actions of non-opioids and their interactions with these systems during inflammation and pain, suggesting that COX inhibition is an incomplete explanation for the actions of non-opioids and proposes the involvement of multiple selective targets for their analgesic, as well as, their adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 1×
“NF- B expression is one of the integral contributors to iNOS transcription and expression [98].”
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · cited 6×
“(1), the increase in endocannabinoids levels following non-opioids treatment could be explained based on either: 1) the inhibition of their metabolism by FAAH; several nonopioids , including indomethacin, ibuprofen and flurbiprofen, inhibit the activity of FAAH [33] [34] [35], particularly at low pH [35] [36] [37], of…”
InfluentialRisk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741 · cited 1×
“It was proposed that selective COX-2 inhibitors, in contrast to nonselective ones, affect the balance between prothrombotic and antithrombotic eicosanoids, thereby shifting the balance to a prothrombotic state [11].”
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959 · cited 1×
“A binding site for transcription factor NF- B is present in the 5’ promoter region of the IL-6 gene [138].”
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771 · cited 1×
“Over expression of SOCS3 blocks the proinflammatory effects of IL-6 signaling through gp130 [140, 141].”
The Androgen Axis in Recurrent Prostate Cancer
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.-G., Ohgi, K. A., Zhang, J., Rose, D. W., Fu, X.-D., Glass, C. K., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.030 · Cited by 576
Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309523200 · Cited by 505
Högestätt, E. D., Jönsson, B. A. G., Ermund, A., Andersson, D. A., Björk, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., & Zygmunt, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501489200 · Cited by 454
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279 · cited 1×
“4) The CB1 receptor antagonists (AM-281 and SR141716A) prevent the analgesic effects of acetaminophen in the hot plate test [46], and the CB1 receptor antagonist AM-251 blocks the antinociceptive effect”
Ridnour, L. A., Windhausen, A. N., Isenberg, J. S., Yeung, N., Thomas, D. D., Vitek, M. P., Roberts, D. D., & Wink, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702761104 · Cited by 219 · cited 1×
“The modulatory role of NO on MMPs and TIMP expression and/or activity has been shown in rat aortic smooth muscle cells [187], rat primary astrocytes [188] and murine macrophages [189].”
Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women
Dedier, J., Stampfer, M. J., Hankinson, S. E., Willett, W. C., Speizer, F. E., & Curhan, G. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000035856.77718.da · Cited by 145 · cited 1×
“NSAIDs are known to increase blood pressure [191], and acetaminophen was reported to have the same effect [192, 193].”
Guindon, J., & Beaulieu, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.002 · Cited by 90
Alloui, A., Chassaing, C., Schmidt, J., Ardid, D., Dubray, C., Cloarec, A., & Eschalier, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01578-9 · Cited by 83
Effects of acetaminophen on monoaminergic systems in the rat central nervous system
Courade, J.-P., Caussade, F., Martin, K., Besse, D., Delchambre, C., Hanoun, N., Hamon, M., Eschalier, A., & Cloarec, A. (2001) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100100484 · Cited by 79 · cited 3×
“It increases K + -evoked [ 3 H]5-HT overflow from slices of the posterior cortex, but not the striatum, the brain stem or the hypothalamus, eliminating the possibility that changes in 5-HT release/reuptake might account for the increased levels of 5-HT in these areas [52].”
Bonnefont, J., Alloui, A., Chapuy, E., Clottes, E., & Eschalier, A. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00034 · Cited by 74 · cited 1×
“At least in case of acetaminophen, central serotonergic effects appears to be primarily supraspinal [64].”
Liu, P., Li, S., Gan, L., Kao, T. P., & Huang, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2038 · Cited by 67
Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV
Bevilacqua, M., Vago, T., Baldi, G., Renesto, E., Dallegri, F., & Norbiato, G. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90067-1 · Cited by 64 · cited 1×
“Many non-opioids also affect cAMP level, but different studies show varying results [132-134].”
LIN, S., WANG, C., HUANG, S., LEE, J., CHIANG, C., LAN, W., & HONG, C. (2001) · Journal of Endodontics · doi:10.1097/00004770-200103000-00012 · Cited by 59
Raffa, R. B., & Codd, E. E. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00273-1 · Cited by 48 · cited 1×
“acetaminophen possesses no binding affinity to any type of 5-HT receptor or transporter [65], a direct effect on 5-HT receptors or transporters is unlikely and the exact mechanism of acetaminophen effects on 5-HT signaling is yet to be determined.”
Bonnefont, J., Daulhac, L., Etienne, M., Chapuy, E., Mallet, C., Ouchchane, L., Deval, C., Courade, J.-P., Ferrara, M., Eschalier, A., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.025775 · Cited by 39
Cited by
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
Benedetti, F., Amanzio, M., Rosato, R., & Blanchard, C. (2011) · Nature Medicine · doi:10.1038/nm.2435 · Cited by 289
Mechanisms of Taxane Resistance
Maloney, S., Spring, C., Morejon-Lasso, L., & Prosperi, J. (2020) · Cancers · doi:10.3390/cancers12113323 · Cited by 198
Dogrul, A., Seyrek, M., Akgul, E. O., Cayci, T., Kahraman, S., & Bolay, H. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.016 · Cited by 83
Metadata
- Authors
- Hamza, M., & Dionne, R.
- Venue
- Current Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-01-01
- Volume
- 2
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1874-4672 (ISSN-L)
- OpenAlex
- W2093868029
- Cited by
- 108
- References
- 32
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.